➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKinsey
Johnson and Johnson
Merck
McKesson

Last Updated: September 20, 2021

DrugPatentWatch Database Preview

Patent Applications for dorzolamide hydrochloride


Email this page to a colleague

« Back to Dashboard

US Patent Applications for dorzolamide hydrochloride

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
⤷  Free Forever Trial ⤷  Free Forever Trial Method for determining physiological effects of hemoglobin 2002-01-31 Abandoned -- Failure to Respond to an Office Action 2008-08-04
⤷  Free Forever Trial ⤷  Free Forever Trial COMBINED AGENTS FOR TREATMENT OF GLAUCOMA 2002-05-16 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2012-01-09
⤷  Free Forever Trial ⤷  Free Forever Trial Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma 2001-11-05 Abandoned -- Failure to Respond to an Office Action 2004-04-02
⤷  Free Forever Trial ⤷  Free Forever Trial METHODS OF TREATING OPHTHALMIC DISORDERS WITH EPOXY-STEROIDAL ALDOSTERONE RECEPTOR ANTAGONISTS 2002-12-12 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-04-19
⤷  Free Forever Trial ⤷  Free Forever Trial Methods for treating carbonic anhydrase mediated disorders 2003-02-14 Abandoned -- Failure to Respond to an Office Action 2006-12-20
⤷  Free Forever Trial ⤷  Free Forever Trial PROCESS FOR OBTAINING 4-(N-ALKYLAMINO)-5,6-DIHYDRO-4H-THIEN-(2,3-B)-THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDES AND INTERMEDIATES 2003-03-03 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2014-05-19
⤷  Free Forever Trial ⤷  Free Forever Trial Method of administering opthalmic fluids 2004-01-28 Abandoned -- Failure to Respond to an Office Action 2008-11-12
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

WIPO Patent Applications for dorzolamide hydrochloride

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Express Scripts
Merck
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.